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ABSTRACT  Eukaryotic cells, when faced with unfavorable environmental con-
ditions, mount either pro-survival or pro-death programs. The conserved cy-
clin C-Cdk8 kinase plays a key role in this decision. Both are members of the 
Cdk8 kinase module that, along with Med12 and Med13, associate with the 
core Mediator complex of RNA polymerase II. In Saccharomyces cerevisiae, 
oxidative stress triggers Med13 destruction, which releases cyclin C into the 
cytoplasm to promote mitochondrial fission and programmed cell death. The 
SCFGrr1 ubiquitin ligase mediates Med13 degradation dependent on the cell 
wall integrity pathway, MAPK Slt2. Here we show that the AMP kinase Snf1 
activates a second SCFGrr1 responsive degron in Med13. Deletion of Snf1 re-
sulted in nuclear retention of cyclin C and failure to induce mitochondrial 
fragmentation. This degron was able to confer oxidative-stress-induced de-
struction when fused to a heterologous protein in a Snf1 dependent manner. 
Although snf1∆ mutants failed to destroy Med13, deleting the degron did not 
prevent destruction. These results indicate that the control of Med13 degra-
dation following H2O2 stress is complex, being controlled simultaneously by 
CWI and MAPK pathways. 
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INTRODUCTION 
All eukaryotic cells are continually exposed to changing 
environmental conditions. Consequently, they have 
evolved elaborate mechanisms to both sense damage and 
transmit this signal to the nucleus. The resulting response 
varies dependent upon the stress encountered but in gross 
terms cells have to decide whether to activate pro-survival 
or pro-death programs. Despite this being a critical deci-
sion point, what remains understudied are the molecular 
details of how cells decide their fate upon encountering 
unfavorable environments. Previous studies revealed that 
the conserved cyclin C protein plays a key role in this deci-
sion in response to increased environmental reactive oxy-
gen species (ROS) [1-9]. Cyclin C, together with its kinase 
partner Cdk8, Med12 and Med13, form the Cdk8 Kinase 
Module (CKM) of the multi-subunit Mediator complex. This 
complex acts as an interface between DNA bound tran-
scription factors and RNA polymerase II (RNAP-II [10-12]). 
When the CKM module is bound, it predominantly nega-
tively regulates expression of a subset of stress response 
genes [1, 13-16]. Following an increase in environmental 
ROS (induced by H2O2 treatment), this repression is re-
lieved by the nuclear release of cyclin C to the cytoplasm [4, 
7, 8]. Intriguingly, here cyclin C plays a second role direct-
ing stress-induced mitochondrial fission as well as promot-
ing programmed cell death (PCD) [7, 8]. Consistent with 
 
doi: 10.15698/mic2018.08.641 
Received originally: 02.03.2018;  
in revised form: 29.05.2018,  
Accepted 04.06.2018, 
Published 25.06.2018.  
 
 
Keywords: cyclin C, Cdk8, Med13, 
SCFGrr1, AMPK, Snf1, ubiquitin 
mediated destruction, signal 
transduction, H2O2 stress, MAPK. 
 
 
Abbreviations:  
AMPK - 5' adenosine 
monophosphate-activated protein 
kinase, 
CKM – cyclin C/Cdk8 kinase module, 
CWI – cell wall integrity,  
IDR – intrinsic disordered region, 
MAPK - MAP kinase, 
PCD - Programmed cell death, 
ROS – reactive oxygen species, 
Y2H – yeast two hybrid. 
 
S.D. Willis et al. (2018)  Snf1 mediated degradation of Med13 
 
 
OPEN ACCESS | www.microbialcell.com 358 Microbial Cell | AUGUST 2018 | Vol. 5 No. 8 
this function, cells lacking cyclin C are less able to execute 
stress-induced mitochondria fission and are more resistant 
to oxidative stress [3, 7]. Taken together, these results ar-
gue that cyclin C nuclear release must be carefully con-
trolled as it signals a commitment to PCD. 
Our previous studies have revealed that a complex mo-
lecular mechanism controls cyclin C nuclear release. In 
response to environmental ROS, cyclin C is directly phos-
phorylated by Slt2, the MAP kinase of the Cell Wall Integri-
ty (CWI) signal transduction pathway ([6] and Fig. 1A). This 
canonical pathway is characterized by a family of cell-
surface sensors (Wsc1, Mid2 and Mtl1 [17]) that transmit 
the stress to a small G protein Rho1, which thereafter acti-
vates protein kinase C (Pkc1 [18, 19]). Once activated, Pkc1 
transmits the intracellular signal to the MAPK Slt2/Mpk1 
[20] as well as to the pseudo-kinase Kdx1/Mlp1 via the 
MAPK module [21]. In addition to cyclin C [6], Slt2 directly 
phosphorylates two other transcription factors (Rlm1, 
Swi4/Swi6) that stimulate the expression of other stress 
response genes [21-24]. More recently, Slt2 has also been 
shown to regulate gene expression by phosphorylating 
tyrosine-1 of the RNAP II carboxy-terminal domain [25]. 
This event is associated with pause/termination processes 
in mammals [26]. Intriguingly, it is required for the loss of 
cyclin C and Cdk8 from target genes following stress in 
yeast [25].  
 
In S. cerevisiae, Med13 destruction is required for cyclin 
C nuclear release [27]. Consistent with this, cyclin C is cyto-
plasmic in unstressed med13∆ and the mitochondria are 
predominantly fragmented [27]. More recently we identi-
fied SCFGrr1 as the E3 ligase that mediates Med13 destruc-
tion [9]. Like other SCF targets [28], recognition of this 
phospho-degron requires it first to be primed by one ki-
nase (cyclin C-Cdk8) and then activated by another (Slt2). 
These studies also revealed that phosphorylation of cyclin 
C by Slt2 is required for the SCFGrr1 to recognize Med13 ([9] 
and Fig. 1A). Like the Slt2-degron, this domain lies within 
the large intrinsic disordered region (IDR) of Med13 (Fig. 
2A). IDR’s are defined by a continuous stretch of disor-
dered promoting residues which can easily transition into 
more ordered states. These structural transitions afford 
IDR’s great flexibility and as such these regions are known 
to play key roles in macro-molecular decisions especially 
those that influence signaling pathways [29, 30]. 
In addition to Slt2, the highly conserved 5’ adenosine 
monophosphate-activated protein kinase (AMPK), which 
plays a major role in the utilization of alternative carbon 
sources after glucose depletion [32], is also activated in 
response to various environmental stresses including oxi-
dative stress [33]. In S. cerevisiae, the catalytic subunit of 
the heterotrimeric AMPK complex is encoded by SNF1. 
Other members of the complex (outlined in Fig. 1B) include 
two regulatory subunits, the γ subunit Snf4 and one of the 
FIGURE 1: (A) Cdk8 module 
regulation by the CWI 
MAPK pathway. H2O2 stim-
ulates cell wall sensors 
Wsc1, Mtl1 and Mid2, lead-
ing to activation of Rho1 
that in turn triggers the cell 
wall integrity (CWI) MAPK 
pathway by activating Pro-
tein Kinase C (Pkc1). Activa-
tion of this cascade triggers 
the MAPK, Slt2, to directly 
phosphorylate cyclin C, an 
event required for the 1st 
step towards its release 
from the nucleus. The sec-
ond step requires Slt2 to 
directly phosphorylate 
Med13-degron742-844, which 
targets it for ubiquitin me-
diated degradation by 
SCFGrr1. Cyclin C-Cdk8 activi-
ty is needed to prime the 
degron before it is recog-
nized by SCFGrr1 [9]. (B) 
Outline of the AMPK 
pathway in yeast. It re-
mains unknown how this 
pathway is activated in 
response to H2O2 stress. 
The gray box represents the 
Snf1 kinase complex (see 
text for details). 
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three alternative β subunits, Sip1, Sip2, or Gal83 [32]. The 
three β isoforms determine the respective cellular ad-
dresses after activation of Snf1, with the Snf1-Gal83 iso-
form being enriched in the nucleus [34-36]. The catalytic 
activity of Snf1 is regulated by phosphorylation at Thr-210, 
which is located in the activation loop of its kinase domain 
[37]. This is executed by one of three upstream kinases, 
Sak1, Tos3, or Elm1 [33, 38, 39]. These, in turn, are activat-
ed by an unknown mechanism in response to a variety of 
stresses, which lends specificity to the system [33].  
In this report we show that Snf1, Sak1 and at least one 
β isoform are required for the H2O2 induced degradation of 
Med13. Using yeast two-hybrid analysis, the Snf1-
interacting domain on Med13 was identified. This domain 
lies in the large IDR of Med13 and is recognized by SCFGrr1 
after Snf1 directed phosphorylation. Consistent with this, 
Snf1 is required for efficient cyclin C nuclear release follow-
ing H2O2 stress. Taken together, this reveals that Med13 
degradation is regulated by two SCFGrr1 degrons that are 
regulated by three different classes of kinases, a Cdk, a 
MAPK and an AMPK. As all three kinases are required for 
Med13 degradation, this complex molecular mechanism 
ensures that cyclin C nuclear release is tightly controlled 
and prevents its untimely release into the cytoplasm. 
 
RESULTS 
Med13 contains two SCFGrr1 phospho-degrons 
We have previously shown that SCFGrr1 is the E3 ligase re-
sponsible for mediating Med13 degradation following H2O2 
stress [9]. This degron (amino acids 742-844, Fig. 2A,) is 
primed by cyclin C-Cdk8 and activated by Slt2. In these 
studies we also observed that another Med13 domain 
(amino acids 571-650) can also bind to Grr1 using the Gal4 
yeast two hybrid (Y2H) assay [40]. These results were re-
peated using two baits, wild-type Grr1 and a grr1∆F∆L mu-
tant, which can neither bind to the SCF or recognize sub-
strates [41, 42]. As anticipated, the Gal4 activating domain 
Med13571-650 fusion protein (hereon out referred to as 
degron571-650) can associate with wild-type Grr1 as an inter-
action is detected selecting for the dual HIS3 and ADE2 
reporter genes (Fig. 2B). The vector control and mutant 
bait were unable to grow on this media suggesting that the 
interaction is specific.  
To confirm that degron571-650 is responsive to SCFGrr1 we 
examined its degradation, via Western blot analysis, fol-
lowing 0.4 mM H2O2 treatment in wild-type and grr1∆ cells. 
This concentration of H2O2 induces mitochondrial outer 
membrane permeabilization (MOMP) dependent regulated 
cell death response in yeast [43-45] and triggers cyclin C 
nuclear release [4, 6, 7, 27]. The results show that although 
less degron571-650 is present in unstressed grr1∆ cells, the 
protein is more stable following H2O2 stress (Fig. 2C and 
quantified in 2D). Taken together with the Y2H data, these 
results argue that degron571-650 is a SCFGrr1 responsive 
degron. They are also consistent with our previous pub-
lished work demonstrating that Grr1 is required for H2O2 
induced degradation of Med13 [9].  
 
Snf1 is required for stress-induced degradation of Med13 
We next addressed if the H2O2 mediated destruction of 
degron571-650 required Cdk8 kinase activity. To execute this, 
the degradation of degron571-650 was monitored as de-
FIGURE 2: Med13 contains two H2O2 stress responsive degrons. 
(A) Cartoon of the results from ProteinPredict® [89] analysis of 
yeast Med13. The amino and carboxyl terminal domains are struc-
tured and separated by a large intrinsic disordered region. The 
positions of the two degrons are indicated. (B) Yeast two hybrid 
analysis of degron571-650 and Grr1 derivatives. Yeast PJ69-4a cells 
harboring Med13-activating domain plasmid (pDS15) and either 
pAS2, pAS-Grr1 or pAS2-Grr1∆F∆L binding domain plasmids were 
grown on -LEU, -TRP drop out medium to select for both plasmids 
(left panel) and -TRP, -LEU, -HIS –ADE (right panel) to test for 
Med13-Grr1 interaction. (C) Wild-type (RSY10) or grr1∆ cells 
(RSY1770) harboring degron571-650 (pDS15) were treated with 0.4 
mM H2O2 for the timepoints indicated and Med13571-650-HA levels 
analyzed by Western blot. Tub1 levels were used as loading con-
trols. (D) Degradation kinetics of the degron571-650 constructs 
shown in C. Values represent averages ± SD from a total of at least 
two Western blots from two independent experiments. 
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scribed above, in cells deleted for cyclin C harboring either 
functional myc-tagged cyclin C or a vector control. The 
results revealed that degron571-650 is degraded with the 
same kinetics in the presence or absence of cyclin C (Fig. 
S1A and quantified in Fig. S1B). These results suggest that 
another kinase phosphorylates degron571-650. One candi-
date is the PAS kinase. This kinase is required for glucose 
homeostasis, and is encoded by two orthologs Psk1 and 
Psk2 [46]. Intriguingly, previous Y2H studies have revealed 
that a domain of Med13 (amino acids 505-703), that en-
compasses degron571-650, interacts with Psk1 [47]. The Y2H 
assay was repeated using Psk1 as bait and the smaller 
degron571-650 as prey and again an interaction was observed 
(Fig. S2A). We next tested if the PAS kinase plays a role in 
the degradation of full length Med13. Wild-type and psk1∆ 
psk2∆ cells harboring a functional HA-tagged Med13 plas-
mid [9] were treated with H2O2 and Med13 degradation  
was monitored by Western blot analysis. The results show 
that Med13 is degraded with similar kinetics in the mutant 
and wild-type cells (Fig. S2B and quantified in Fig. S2C). 
These results indicate that although the PAS kinase can 
interact with degron571-650, it is not required for Med13 
degradation following H2O2 stress. 
PAS kinase activation by carbon sources is dependent 
on the Snf1 complex [48, 49]. Since Snf1 has many targets 
[50], we next tested if Snf1 mediates Med13 degradation 
following H2O2 stress as just described. The results show 
that Med13 is significantly more stable in snf1∆ cells (Fig. 
3A and quantified in Fig. 3C). Similar results were obtained 
when the Snf1 kinase dead mutant (K84R, [51]) was the 
only source of Snf1 (Fig. 3B and quantified in Fig. 3D). Tak-
en together, these results indicate that Snf1 activity is re-
quired for Med13 degradation following H2O2 stress.  
Sak1 has been identified as the AMPK kinase that is ac-
tivated in response to oxidative stress [33]. Therefore, we 
next addressed if Sak1 is required for H2O2 induced Med13 
degradation. The degradation assays described above were 
repeated in sak1∆ cells and results revealed that Med13 
was again significantly more stable in sak1∆ than wild-type 
cells (Fig. 3A and quantified in Fig. 3C). This result supports 
FIGURE 3: Snf1, Sak1 and at least one β subunit are required for degradation of Med13 following H2O2 stress. (A) Wild-type (RSY10), 
snf1∆ (RSY2080), sak1∆ (YPDahl17) and gal83∆ sip1∆ sip2∆ (MSY557) cells harboring full length  Med13-HA (pKC801) were treated with 
0.4 mM H2O2 for the timepoints indicated and Med13-HA levels analyzed by Western blot. Tub1 levels were used as a loading control. (B) 
snf1∆ cells harboring Med13-HA (pKC803) and either wild- type Snf1 (JG1193), a vector control (pRS316) or snf1K84R (JG1338) were treat-
ed and analyzed as described in (A). (C and D) Degradation kinetics of the Med13-HA shown in A and B. Values represent averages ± SD 
from a total of at least two Western blots from independent experiments. 
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the previously proposed model that Sak1 is the AMPKK 
that activates Snf1 in response to oxidative stress [33]. We 
next addressed if the nuclear enriched isoform, Snf1-Gal83, 
[34-36, 52], is required for Med13 degradation under simi-
lar circumstances. Unexpectedly, the results show that 
Med13 is still degraded in gal83∆ cells (Fig. S3A). Likewise, 
similar results were obtained when Med13 degradation 
was monitored in a sip1∆ sip2∆ strain (Fig. S3A). However, 
deletion of all three β subunits significantly inhibited the 
degradation of Med13 to a similar extend as observed in 
snf1∆ (Fig. 3A and quantified in Fig. 3C). Taken together, 
this suggests at least one of the β subunits of the Snf1 
complex is required for Med13 degradation following H2O2 
stress.  
 
Snf1 activation alone is not sufficient to mediate Med13 
degradation 
We next addressed if Snf1 activation was sufficient to me-
diate Med13 degradation in the absence of H2O2 stress. To 
execute this Med13 levels were examined in wild-type cells 
after they had been switched from 2% to 0.05% glucose 
which, is sufficient to activate Snf1 (Fig. 4A and [33]). No 
differences in Med13 levels were observed following glu-
cose deprivation (Fig. 4B). Taken with the results presented 
in Fig. 3, this suggests that Snf1 activation is necessary but 
not sufficient to mediate the degradation of Med13 follow-
ing H2O2 treatment.  
 
The CWI pathway sensors proteins are not required for 
Snf1 activation 
It is known that both the CWI and AMPK pathways are ac-
tivated in response to oxidative stress, but how these two 
pathways communicate is not well understood [53]. Im-
portantly, although it is known how the signal is transmit-
ted to the CWI pathway, it is unclear how the AMPK path-
way is activated (Fig. 1B). One possibility is that the path-
ways crosstalk through the cell wall sensor proteins. To 
test this, we examined Snf1 phosphorylation status in a 
strain lacking the three cell wall sensors (Wsc1, Mid2 and 
Mtl1, [17]). Consistent with previously published work [33], 
Snf1 is phosphorylated following H2O2 treatment in a Sak1 
dependent manner (Fig. 4C). Likewise the cell wall sensor 
triple mutant is also able to activate Snf1 following H2O2 
treatment (Fig. 4C). These results suggest that the activa-
tion of the CWI pathway is not required to transmit the 
stress signal to the AMPK pathway. Others have demon-
strated that Snf1 is not required for activation of Slt2 [54]. 
Consistent with this, we observed that the Med13 
degron571-650 is still degraded following H2O2 stress when a 
mutant of cyclin C, that cannot be phosphorylated by Slt2 
(S266A, [6]), is used as the sole source of cyclin C (Fig. S1C 
and D). Taken together, these results argue that the AMPK 
and MAPK signaling pathways act independently of each 
other. The extension of this conclusion is that both path-
ways contribute independently to regulating Med13 de-
struction following H2O2 stress. 
 
 
 
The Snf1 degron lies within the IDR of Med13 
Snf1 has previously been shown to phosphorylate a SCFGrr1 
phospho-degron in Pfk27, a key regulator of glycolysis [55]. 
Taking this into account, we asked if the Gal4 activating 
domain Med13571-650 fusion protein (degron571-650) is a Snf1 
responsive degron by monitoring its H2O2 mediated degra-
dation snf1∆ cells. The results show that degron571-650 is 
more stable in snf1∆ cells compared to wild type following 
H2O2 stress (Fig. 5A and quantified in Fig. 5B). This suggests 
that degron571-650 is a Snf1 responsive degron. To further 
support this conclusion, we examined the degradation 
kinetics of a degron mutated for either of the potential 
Snf1 phosphorylation sites previously identified in proteo-
mic screens (S587 [56] and S636 [57], Fig.6A), although 
none of these sites perfectly fit the Snf1 consensus se-
quence [58, 59]. The studies revealed that both mutants 
were degraded following H2O2 treatment with kinetics 
similar to wild type (Fig. S3B). We also noted that serine 
634 could potentially be phosphorylated by Snf1 (see Fig. 
6A). As it lies very close to serine 636, we made a double 
mutant (S634A, S636A) and repeated the assay. Again this 
mutant degron was degraded following H2O2 treatment (Fig. 
S3B). However, the triple mutant (S587A, S634A, S636A) 
exhibited enhanced stability following H2O2 stress (Fig. 5C 
and quantitated in Fig. 5B). Taken together, these results 
suggest that Snf1 phosphorylates Med13 following H2O2 
stress targeting S587, S634 and S636. Consistent with this 
FIGURE 4: Snf1 activation does not mediate Med13 degradation. 
(A) Mid-log -type cells (RSY10) growing in 2% glucose (T=0) were 
switched to media containing 0.05% glucose. Snf1 phosphoryla-
tion and Snf1 itself were detected as described in materials and 
methods for the timepoint indicate. (B) Wild-type cells harboring 
Med13-HA (pKC801) were switched to media containing 0.05% 
glucose. Med13-HA levels were detected by Western blot analysis 
for the timepoints indicated. Tub1 was used as a loading control. 
(C) As in (A) except that Snf1 phosphorylation was monitored 
after 0.4 mM H2O2 treatment in the strains indicated. 
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model, we (Fig. 5D and S3C) and others [60] have shown 
that Snf1 can co-immunoprecipitate with Cdk8 both before 
and after H2O2 stress. As cyclin C directly binds  to the adja- 
cent degron742-844 (Fig. 2A and [9]), this places Snf1 in close 
proximity to degron571-650. In addition, these data also sup-
port the notion suggested by others, that a subpopulation 
of Snf1 is nuclear in unstressed cells [34, 52, 60].  
To address if Snf1 directly phosphorylates Med13, ki-
nase assays were performed with wild-type and kinase 
dead Snf1 (K84R). The activated kinase was immunoprecip-
itated from yeast extracts and incubated with GST-
Med13561-650, S608A purified from E. coli. Serine 608 was mu-
tated to alanine as it potentially is contaminating PAS ki-
nase site (Fig. 5E and [49]). In addition, although this site 
has also been identified as target of PKA mediated phos-
phorylation [61], we have previously shown that this site 
does not play a role in Med13 degradation in response to 
oxidative stress [9]. Lastly, it is documented that Snf1 does 
FIGURE 5: Snf1 phosphorylates degron571-650. (A) Mid-log wild-type (RSY10) or snf1∆ cultures (RSY202) harboring degron571-650 (pDS15) were 
subjected to an H2O2 timecourse experiment and protein extracts analyzed by Western blot. Tub1 levels were used as loading controls. (B) 
Degradation kinetics of degron571-650 shown in (A) and (C). Values represent averages ± SD from a total of at three Western blots from inde-
pendent experiments. (C) As in (A) except that degron571-650,S587A, S634A, S636A (pDS56) was analyzed in wild-type cells. (D) Co-
immunoprecipitation analysis of Snf1-myc and Cdk8-HA. Mid log wild-type cells harboring Snf1-myc and Cdk8-HA on single copy plasmids 
were treated with 0.4 mM H2O2 for the timepoints shown. Protein extracts were immunoprecipitated with anti-HA,  separated by SDS-PAGE 
Western analysis and the membrane probed with the antibodies shown. [] represents no IP antibody and the asterisk represents the heavy 
chain. See Fig. S3C for vector control. (E) Potential phospho-sites in Med13571-650. (F) Upper panels: Kinase assays using Snf1 and Snf1K84R-myc 
(kinase dead) immunoprecipitated from yeast protein extracts prepared from either wild type (left panel) or cdk8∆ cells (right panel) and 
Med13-degron571-650 (GST-Med13571-906,S608A purified from E. coli) as the substrate. The reactions were separated by SDS PAGE and subject to 
autoradiography. Lower panels: Coomassie stained gels showing the input used in the kinase assays.  
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not phosphorylate GST, so this control was not included 
here [62]. The results (Fig. 5F) show that Snf1 is able to 
directly phosphorylate degron571-650. However, despite tak-
ing the precautions listed above, kinase activity was also 
observed using the kinase dead version. This suggests that 
another kinase that immunoprecipitates with Snf1 is able 
to phosphorylate this degron. One strong possibility is 
Cdk8, which is a proline directed kinase that can phosphor-
ylate the minimal consensus sequence S/T-P [63]. 
Degron571-650 contains one such site (Fig. 5E). Therefore the 
kinase assays were repeated using Snf1 extracts isolated 
from a cdk8∆ strain. The results show that degron571-650 was 
phosphorylated by Snf1 and this activity was reduced in 
the kinase dead control (Fig. 5F). Taken together, these 
results are suggestive that Snf1 directly phosphorylates 
Med13571-650. However, as some phosphorylation of 
degron571-650 was observed when Snf1K84R was used, we 
cannot rule out the possibility that an intermediary kinase 
may be playing a role. 
 
Other potential Snf1 sites on Med13 are not needed for 
its degradation following H2O2 stress 
The Snf1 proteomic screen mentioned above also identi-
fied five additional potential Snf1 sites in Med13 [57]. Intri-
guingly, these sites all lie within the large IDR of Med13 (Fig. 
6A). As IDR’s provide ideal environments for post-
translational modifications, which effect signaling events 
[64], we asked if these additional sites also play a role in 
Med13 degradation. To address this question, Med13-HA 
fragments were fused to the SV40 nuclear localization se-
quence (NLS) and assayed for H2O2 mediated destruction. 
The results revealed that the construct that contains both 
degrons as well as all the potential Snf1 sites (amino acids 
306-906) is degraded. However, the Med13306-570 construct, 
that contains the remaining potential Snf1 sites but not the 
two SCFGrr1 responsive degrons, was significantly more sta-
ble (Fig. 6B). This suggests that these other potential Snf1 
sites do not play a role in the H2O2-stress mediated degra-
dation of Med13. To address if the head and tail regions of 
Med13 contain unidentified Snf1 sites, Med13 constructs 
spanning these regions (amino acids 1-306 and 907-1420) 
were also tested, as described above, for stability following 
H2O2 stress. The results (Fig. 6C) demonstrate that these 
constructs are not destroyed under these conditions. This 
supports our conclusion that the Snf1 degron lies within 
amino acids 571-650. Degron742-844 also contains a potential 
Snf1 target site (Fig. 6A). However, this degron, when fused 
to the Gal4 activating domain, is destroyed following H2O2 
stress in wild-type and snf1∆ cells alike (Fig. 6D). Taken 
together, these results support the above conclusions that 
the Snf1 phosphorylation sites lie within degron571-650. 
 
Snf1 is necessary for cyclin C nuclear release and stress-
induced mitochondrial fission 
As Med13 degradation is required for cyclin C nuclear re-
lease [9, 27], we next tested if Snf1 was also required for 
this event. To address this, the location of a functional cy-
clin C-YFP reporter protein [5] before and after stress in 
wild-type and snf1∆ cells was examined (Fig. 7A and quan-
tified in 7B). The results show that a majority of cyclin C-
YFP is cytoplasmic in wild-type cells, whereas it remains 
significantly more nuclear in snf1∆ cells (Fig. 7A and quanti-
fied in 7B). These data indicate that Snf1 is required for the 
oxidative stress induced nuclear release of cyclin C. As cy-
clin C nuclear release initiates stress-induced mitochondrial 
fission [4, 7, 8], mitochondrial morphology in snf1∆ cells 
was examined. As previously reported, unstressed wild-
type  cells  exhibited   mainly  reticular  mitochondrial  mor- 
FIGURE 6: Other potential Snf1 sites in Med13 are not required 
for its degradation following H2O2 stress. (A) Map of Med13 out-
lying the positions of the two Med13 degrons, the consensus Snf1 
target site [57] and potential Snf1 sites, identified by published 
proteomic screens. (B) and (C) Wild-type (RSY10) cultures harbor-
ing the NLS-Med13-HA constructs shown were grown to mid-log 
phase (0 h) then treated with 0.4 mM H2O2 for the indicated 
times. Med13-HA levels were determined by Western blot analy-
sis. Tub1 levels were used as a loading control. (D) Mid-log wild 
type or snf1∆ cultures (RSY202) harboring HA tagged Med13 
degron742-844 (pDS32) were subjected to an H2O2 timecourse 
experiment and protein extracts analyzed by Western blot. Tub1 
levels were used as loading controls. 
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phology (Fig. 7C) that switched to a predominantly frag-
mented phenotype after 3 hours of 0.4 mM H2O2 treat-
ment. In snf1∆ cells, significantly less fragmented mito-
chondria are seen after H2O2 treatment. Taken together, 
these results indicate that activation of Snf1 is required for 
stress-induced mitochondrial fragmentation through cyclin 
C nuclear release. 
 
Med13-degron571-650 is not required for the degradation of 
Med13 following H2O2 stress  
We next addressed if Snf1 mediated phosphorylation of 
Med13 is required for Med13 degradation. Degron571-650 
was deleted from full length Med13 and the degradation 
kinetics of this construct (Med13deg∆571-650) was examined in 
med13∆ cells. The results show that Med13deg∆571-650 was 
degraded with kinetics similar to wild type (Fig. 8A upper 
two panels, quantified in Fig. 8B). We also observed that 
this construct retained cyclin C in the nucleus in unstressed 
cells and released it into the cytoplasm following H2O2 
stress (Fig. S5). These results were unexpected as deletion 
or inactivation of Snf1 results in Med13 stabilization fol-
lowing H2O2 stress (Fig. 3). Similarly, deletion of the Slt2 
responsive degron (amino acids 742-844) only partially 
rescued the deletion (Fig. 8A, bottom two panels) whereas 
Med13 is significantly stabilized in slt2∆ cells following 
H2O2 stress [9]. These results suggest a complex model in 
FIGURE 7: Cyclin C remains predominantly nuclear following H2O2 stress in snf1∆. (A) Fluorescence microscopy of mid-log phase wild-type 
and snf1∆ cells harboring a cyclin C-YFP expression plasmid (pBK38). Cells were stained with Dapi to visualize the nucleus. (B) Quantifica-
tion of the results obtained in (A). At least 200 cells were counted per timepoint from 3 individual isolates. The percent of cells (mean ± 
SEM) within the population displaying cytoplasmic cyclin C is given. * p<0.05 difference from wild type. (C) Right panel: representative 
images of the two mitochondrial morphologies scored. Left panel: as in (B) except that percent of cells displaying fragmented mitochondria 
was scored. Representative images of the mitochondrial morphologies scored are shown in the left hand panel. The percent of cells (mean 
± s.e.m.) within the population displaying fragmented mitochondria is given. * p<0.05 difference from wild type. ** p<0.01 difference from 
wild type. Bar  = 13 µM. 
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which the function of either Snf1 or Slt2 is only required 
when their respective degron is present. If correct such a 
model would predict that the degron impeaches degrada-
tion when not phosphorylated. Moreover, these studies 
predict independent roles for these two signaling pathways 
that ultimately direct in the same outcome of Med13 deg-
radation. 
 
DISCUSSION 
Our previous work has shown that nuclear release of the 
yeast and mammalian cyclin C predisposes cells to initiate 
PCD following stress [7, 8]. In S. cerevisiae, this nuclear 
release requires the destruction of Med13 [27], mediated 
by the E3 ligase complex SCFGrr1, which requires Slt2 and 
Cdk8 activity [9]. In this current work, we provide evidence 
that Sak1 activated Snf1 is also required for H2O2 induced 
Med13 degradation and cyclin C nuclear release. In the 
absence of this kinase, Med13 degradation following H2O2 
stress is inhibited and cyclin C remains predominantly nu-
clear. Consistent with this model, we showed that Snf1 is 
required for the degradation of the degron571-650. Paradoxi-
cally, deletion of this degron did not prevent H2O2 induced 
destruction of Med13. Instead, this mutant exhibited H2O2 
induced Med13 degradation and cyclin C nuclear release. 
Intriguingly, deletion of the Slt2-resonsive degron 
(Med13742-844) also did not protect Med13 from H2O2 in-
duced degradation, although the protein was slightly more 
stable than wild type. Taken together, this study indicates 
that Slt2 and Snf1 pathways cooperate to trigger Med13 
destruction. The use of two required pathways may help 
insure the proper signals are in place to target Med13. 
To accommodate these two results, the following mod-
el that best fits the data is proposed (outlined in Fig. 8C). In 
unstressed cells the IDR of Med13, which encompasses 
both degrons, is protected from SCFGrr1 activity (depicted 
by red circle in Fig. 8C) by an unknown mechanism. Follow-
ing H2O2 stress two events happen, the hierarchy of which 
is unknown. The protection is lost (depicted by green circle 
in Fig. 8C) and activated Snf1 and Slt2 phosphorylate their 
respective degrons, triggering SCFGrr1 mediated degrada-
tion of Med13. Although we currently favor the hypothesis 
that Snf1 directly phosphorylates Med13, we could not 
definitively exclude the possibility that Snf1 may promote 
Med13 phosphorylation indirectly via an intermediary ki-
nase. That being said, the model presented in Fig. 8C could 
accommodate this possibility. More importantly however, 
the model supports the observation that both the AMPK 
and MAPK pathways act independently of each other (Fig. 
4), and are required for Med13 degradation. However, in 
the absence of either the Snf1 or Slt2 degron, this protec-
tion is lost, allowing SCFGrr1 to recognize either activated 
degron. This model also accounts for the observation that 
when either degron is expressed in isolation, it requires its 
respective kinase to render it recognizable by SCFGrr1. 
If this model is correct, then how could this region be 
protected from AMPK and MAPK activity in unstressed 
cells? One strong possibility could be connected to the fact 
that both degrons lie within the very large IDR of Med13 
(Fig. 2A).  IDR’s  are known  to  endow  proteins with  highly 
FIGURE 8: Either Med13 degron is sufficient for Med13 degradation. (A) 
med13∆ (RSY1701) cells harboring either Med13571-650deg∆-HA (pKC805, 
upper panels) or Med13742-844deg∆-HA plasmids (pKC814, lower panels) 
were treated with 0.4 mM H2O2 for the timepoints indicated and 
Med13deg∆-HA levels analyzed by Western blot. Tub1 levels were used as 
a loading control. (B) Degradation kinetics of the results shown in (A). 
Values represent averages ± SD from a total of at least two Western blots 
from independent experiments. For clarity, the degradation kinetics of 
wild-type Med13-HA from previous experiments was included. (C) Model 
depicting how two SCFGrr1 phospho-degrons mediate the destruction of 
Med13 following H2O2 stress. In unstressed cells cyclin C-Cdk8 phosphor-
ylates degron742-844 [9] but both degrons are protected by an unknown 
mechanism from Snf1 and Slt2 kinase activity (depicted by the red circle).  
Following H2O2 stress Snf1 and Slt2 are activated and permitted access to 
the now exposed degrons. This results in SCFGrr1 mediated degradation of 
Med13 and cyclin C nuclear release (not shown). 
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malleable structures that undergo disorder-to-order transi-
tions [65]. It has also been proposed that IDR’s can have 
different binding partners that transiently associate [66]. In 
some cases, this can lead to proteins binding the same 
region that possess unrelated, or even opposite functions 
[67]. Thus, proteins that contain IDR’s are frequently in-
volved in signaling as they can easily change their confor-
mational state in response to changing environmental con-
ditions. Taken together, it is feasible to propose that in 
unstressed cells, the IDR of Med13 is in one conformational 
state that associates with an unknown protein, conferring 
protection to this region. Upon stress, the confirmation 
changes and the degron becomes exposed. This model is 
also consistent with the observation that IDR’s are notori-
ous for being regulated by multiple kinases [64, 68]. This 
has led to the idea that IDR’s and multiple phosphorylation 
events together provide structural variability [69], resulting 
in ultra-sensitive molecular switches that are triggered at a 
threshold level of phosphorylation. Thus, our results sug-
gest a model in which Med13 degradation is regulated by 
three types of different kinases, a cyclin dependent kinase, 
a MAPK and an AMPK.  
Lastly, here we show that Snf1 phosphorylates Med13, 
either directly or by an intermediary kinase, as well as as-
sociating with the CKM before stress (Fig. 5D). These re-
sults are consistent with a growing number of papers that 
have shown that a sub-population of the Snf1-Gal3 isoform 
is present in the nucleus under normal conditions [52, 60, 
70], as well as enriched in the nucleus upon glucose starva-
tion [34-36]. In addition, Sak1 is needed for Snf1 nuclear 
localization [71]. In support of this model, Snf1, Gal83 and 
Sak1 localize to the SUC2 promotor under non-starvation 
conditions [52]. This promotor is also negatively regulated 
by the CKM [72]. Repression is relieved by Snf1 mediated 
phosphorylation of two proteins known to repress SUC2 
expression, the DNA binding protein Mig1 [73] and the 
glucose kinase Hxk2 [52, 74], causing them to be released 
into the cytoplasm [75, 76]. Likewise, carbon starvation 
results in the degradation of cyclin C [2], one event that 
occurs in the cytoplasm [4]. Surprisingly, we found that 
although Sak1 is needed for Med13 destruction following 
H2O2 stress, deletion of Gal83 has no effect (Fig. 3A and 
S2A). However, deletion of all three β-subunits does inhibit 
Med13 degradation. This would suggest that in the ab-
sence of Gal83, either Sip1 or Sip2 are able to activate nu-
clear Snf1. However, the Snf1-Sip1 and Snf1-Sip2 isoforms 
have not been reported to be nuclear, dispersing either to 
the vacuolar membrane (Sip1) or remaining cytoplasmic 
following carbon deprivation (Sip2) [34-36, 77]. Further 
studies need to be executed to address if Sip1 or Sip2 can 
translocate into the nucleus in the absence of Gal83. Intri-
guingly, just recently the Mitochondrial Voltage-Dependent 
Anion Channel Protein Por1 (yVDAC1) has been shown to 
enhance Snf1 nuclear enrichment by promoting the nucle-
ar enrichment of Gal83 [70]. This unexpected finding 
serves to emphasize that there is still much to learn about 
the role Snf1 kinase plays in response to changing envi-
ronmental conditions. 
 
MATERIALS AND METHODS 
Yeast strains and plasmids  
All strains used in this study are listed in Table S1. Most exper-
iments were performed in the S. cerevisiae W303 strain [78] 
and are listed in Table S1. Exceptions to this are the sak1∆ 
(YPDahl17, a gift from S. Hohmann [79]), the sip1∆ sip2∆ 
(MML1445, a gift from E. Herrero) and psk1∆ psk2∆ strains 
which are W303-1A strains. The sip1∆ sip2∆ gal83∆ strain 
(MSY557, a gift from M. Schmidt [80]) is an S288c strain. Final-
ly, the Y2H assays were performed in PJ69-4a [40] that was 
obtained from the Yeast Resource center, a gift from S. Fields. 
In accordance with the Mediator nomenclature unification 
effort [81], we use CNC1 and CDK8 gene designations for cy-
clin C (SSN8/UME3/SRB11) and Cdk8 (SSN3/UME5/SRB10) 
respectively. The snf1∆ and gal83∆ strains (RSY1949 and 
RSY2080 respectively) were constructed using gene replace-
ment methodology as described [82]. The sak1∆ (RSY1976) 
was a gift from S. Hohmann [79]. All cells were grown at 30°C.  
All plasmids used in this study are listed in Table S2. The 
wild-type epitope tagged plasmids pKC801, pKC803 (MED13-
HA), pBK38 (ADH1Pro-CNC1-YFP), Snf1-Myc and ADH1Pro-CNC1-
MYC (pKC337) are functional and have been previously de-
scribed [1, 4, 5, 9, 83, 84]. All other plasmids were constructed 
using PCR cloning techniques and details are available upon 
request. In short, all constructs were amplified from plasmid 
DNA using Phusion Taq (Thermo), digested using Thermo fast 
digest restriction enzymes and ligated using Thermo fast ligase 
into their respective vectors. Site directed mutagenesis (New 
England Bio-Labs Q5) was used to create plasmids harboring 
amino acid mutations and the change was confirmed by se-
quencing (Eurofins Genomics). The MED13 Y2H plasmids were 
constructed by PCR cloning regions of Med13 in frame with 
the Gal4 activating domain of pACT2. The NLS-Med13 fusion 
constructs were made by first creating a backbone vector 
(pNLS-HA) that contains the SV40 nuclear localization se-
quence (NLS) in frame with a single HA epitope tag under the 
control of the ADH1 promotor. PCR-cloning was then used to 
place fragments of Med13 in frame with NLS. All in frame fu-
sion proteins were verified by sequence analysis. Other plas-
mids that were used in this study that have been previously 
described. 
 
Cell growth  
Yeast cells were grown in either rich, non-selective medium 
(YPDA) or synthetic minimal medium (SC) allowing plasmid 
selection as previously described [1]. For all experiments, the 
cells were grown to mid-log phase (~ 6x106 cells/ml) before 
treatment with low concentrations of 0.4 mM H2O2 as previ-
ously described [5]. 25 ml of cells were collected per timepoint, 
washed in water, then the pellet flash frozen in liquid nitrogen. 
Yeast two hybrid experiments were executed as described [41]. 
E. coli cells were grown in LB medium with selective antibiotics. 
For the kinase assays cells were initially grown in SD-Ura (1.7 g 
Yeast Nitrogen Base, 5 g Ammonium Sulfate, 20 g Dextrose 
per liter), overnight, diluted 1:100-fold into 500 ml of SD-Ura, 
and grown for 10–12 h. Thereafter the cells were pelleted, and 
resuspended in 500 ml SGal-Ura (1.7 g Yeast Nitrogen Base, 5 
g Ammonium Sulfate, 20 g Galactose per liter) 
 
Western blot analysis and co-immunoprecipitation 
Tagged full length Med13-HA constructs were detected by 
using NaOH lysis of cell pellets exactly as described in [9]. To 
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detect Med13-HA, 1 in 5000 dilutions of anti-HA antibodies 
(Abcam) were used. The co-immunoprecipitation analysis was 
performed essentially as described [85]. Anti-alpha tubulin 
antibodies (12G10) were obtained from the Developmental 
Studies Hybridoma Bank, University of Iowa. Western blot 
signals were detected using either goat anti-mouse or goat 
anti-rabbit secondary antibodies conjugated to alkaline phos-
phatase (Sigma) and the CDP-Star chemiluminescence kit 
(Thermo). Signals were quantitated by CCD camera imaging 
(Kodak) and standardized to the loading control. All degrada-
tion assays were performed two or three times. SEM’s were 
generated for each point (error bars are indicated on the 
graphs) and the data analyzed using linear regression analysis 
using GraphPad Prism 7 program.  
 
Snf1 activation and kinase assays 
The Snf1 activation assays were executed as follows. Cells 
were grown to mid-log phase and treated with 0.4 mM H2O2 
for the times indicated They were immediately boiled for 3 
minutes and pellets frozen using liquid nitrogen. Protein ex-
tracts were made using the NaOH method described in [9] and 
analyzed by SDS-PAGE and Western blotting. Anti-phospho-
Thr172–AMPK (Cell Signaling Technology; Cat. No. 2531) was 
used to detect phosphorylated Snf1 and polyhistidine anti-
body H1029 (Sigma-Aldrich) to detect Snf1. This is possible as 
Snf1 ORF contains 13 contiguous histidine residues at its N 
terminus. 
The in vitro kinase assays were executed as follows. Wild-
type or cdk8∆ cells harboring either myc-tagged Snf1 or Snf1 
kinase dead (K84R) under the control of the GAL1-10 promo-
tor, were first grown in SD-Ura followed by SGal-Ura as de-
scribed above and then resuspended in lysis buffer (20 mM 
HEPES, 10 mM KCl, 1 mM EDTA, 1 mM ethylene glycol tetra-
acetic acid (EGTA), 50 mM NaCl, 10% glycerol, 1 mM β-
mercaptoethanol, Pierce™ Protease Inhibitor Tablets, pH 7.4 
with phosphatase inhibitors). Resuspended cultures were 
lysed using a Microfluidics M-110P homogenizer (Microfluid-
ics) and cell debris removed by centrifugation at 12,000 x g for 
30 min. Supernatants were incubated with 5–10 µl of Myc-
conjugated magnetic beads (Cell Signaling) for 2–3 h at 4°C. 
Beads were separated using magnetic force and washed four 
times with 1 ml of lysis buffer lacking protease inhibitors. 
Beads containing Myc-tagged proteins were used directly for 
in vitro kinase assays without eluting. GST-Med13571-650S608A 
was purified from E. coli BL21 DE3 strain as previously de-
scribed [9] and incubated with the Snf1 immunoprecipitates in 
30 μl of reaction buffer containing 1X Snf1 kinase buffer (50 
mM Tris-HCl, 10 mM MgCl2, 1 mM dithiothreitol (DTT), pH 7.5, 
10 μM ATP, and 7.5 μCi of γ32P-ATP, and reactions were incu-
bated for 35 min at 30°C. Kinase assays were stopped by the 
addition of SDS–PAGE sample buffer, analyzed by SDS-PAGE, 
stained with coommassie (30 min), destained for 2 h, dried 
and exposed to film. 
 
 
 
Fluorescence Microscopy 
Cyclin C-YFP subcellular localization and mitochondrial mor-
phology were monitored as described previously [4, 7]. For all 
experiments, the cells were grown to mid-log (6x106 cells/ml), 
treated with 0.4 mM H2O2 for the timepoints indicated, then 
analyzed by fluorescence microscopy. Cyclin C-YFP release 
analysis was performed on cells stained with DAPI in mounting 
medium (10 mg/ml p-phenylenediamine, 50 ng/ml 4',6-
diamidino-2-phenylindole, Molecular Probes) to visualize nu-
clei and prevent photo bleaching. Images were obtained using 
a Nikon microscope (model E800) with a 100X objective with 
1.2X camera magnification (Plan Fluor Oil, NA 1.3) and a CCD 
camera (Hamamatsu model C4742). Data were collected using 
NIS software and processed using Image Pro software. All 
images of individual cells were optically sectioned (0.2 µM 
slices at 0.3 µM spacing) deconvolved and the slices were 
collapsed to visualize the entire fluorescent signal within the 
cell. Cyclin C-YFP foci were scored as being cytoplasmic when 
3 or more foci were observed outside of the nucleus. Mito-
chondrial fission assays were performed on live cells as de-
scribed [7]. In brief, mitochondrial fission was scored positive 
if no reticular mitochondria were observed that transversed 
half the cell diameter. Fusion was scored when cells exhibited 
one or more reticular mitochondria the diameter of the cell. 
Fission and fusion was scored for 200 cells from three inde-
pendent isolates. Statistical analysis was performed using the 
Student’s T-test. 
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